PATENT CLAIM ANALYSIS

Application Number: 15900589
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["435", "069100"]

Abstract:
The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Claim (Index 57):
The method of  claim 44 , wherein\n (a) the heavy chain variable domain amino acid sequence comprises (SEQ ID NO: 9) EVQLVESGGGLVQPGGSLRLSCAASGFTLSRFAMSWVRQAPGRGLEWVAS   INNGNNPYYARSVQYRFTVSRDVSQNTVSLQMNNLRAEDSATYFCAKDHP   SSGWPTFDSWGPGTLVTVSS; and\n (b) the light chain variable domain amino acid sequence comprises \n (SEQ ID NO: 8) DIQLTQSPSALPASVGDRVSITCRASENVGDWLAWYRQKPGKAPNLLIYK   TSILESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYXRFPYTFGQ   GTKLEIKRTV, wherein X is I or M.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15246301', '14728826', '14981643', '13786215', '14103715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.686599026990252
- 35 USC 102 Novelty (BERT): 0.5879400722212069
- Combined Prediction Score: 0.6767331315133475
- Mean Citation Score: 487.27792199999993
- Max Citation Score: 497.9231
- Similarity Product: 439.5423755830705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test